A trial to test the safety of a drug.
Phase 1
Completed
- Registration Number
- CTRI/2017/11/010680
- Lead Sponsor
- SK Biolabs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Healthy Human Volunteers
Exclusion Criteria
Patients suffering from any disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Any toxic side effects after oral administration of SKBSITA such as fever, nausea, vomiting, cramps, headache, stomachache, backache, palpitations, dizziness, paralysis,skin rashes, choking, numbness, anxiety, depression, cough, shortness of breath etc.Timepoint: 4 Hours
- Secondary Outcome Measures
Name Time Method Any toxic side effects after oral administration of SKBSITA such as fever, nausea, vomiting, cramps, headache, stomachache, backache, palpitations, dizziness, paralysis,skin rashes, choking, numbness, anxiety, depression, cough, shortness of breath etc.Timepoint: 15 days